These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12853839)

  • 41. LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast.
    Lininger RA; Park WS; Man YG; Pham T; MacGrogan G; Zhuang Z; Tavassoli FA
    Hum Pathol; 1998 Oct; 29(10):1113-8. PubMed ID: 9781650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
    Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
    Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
    Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.
    van Rhijn BW; Vis AN; van der Kwast TH; Kirkels WJ; Radvanyi F; Ooms EC; Chopin DK; Boevé ER; Jöbsis AC; Zwarthoff EC
    J Clin Oncol; 2003 May; 21(10):1912-21. PubMed ID: 12743143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens.
    Liu J; Babaian DC; Liebert M; Steck PA; Kagan J
    Mol Carcinog; 2000 Nov; 29(3):143-50. PubMed ID: 11108659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of chromosome 9 in human bladder cancer.
    Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
    Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.
    Natrajan R; Louhelainen J; Williams S; Laye J; Knowles MA
    Cancer Res; 2003 Nov; 63(22):7657-62. PubMed ID: 14633686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
    Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
    Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
    Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J
    Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers.
    Miyamoto H; Kubota Y; Fujinami K; Dobashi Y; Kondo K; Yao M; Shuin T; Hosaka M
    Oncol Res; 1995; 7(7-8):327-30. PubMed ID: 8747595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
    Baffa R; Gomella LG; Vecchione A; Bassi P; Mimori K; Sedor J; Calviello CM; Gardiman M; Minimo C; Strup SE; McCue PA; Kovatich AJ; Pagano F; Huebner K; Croce CM
    Am J Pathol; 2000 Feb; 156(2):419-24. PubMed ID: 10666370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular analysis of PTEN and MXI1 in primary bladder carcinoma.
    Wang DS; Rieger-Christ K; Latini JM; Moinzadeh A; Stoffel J; Pezza JA; Saini K; Libertino JA; Summerhayes IC
    Int J Cancer; 2000 Nov; 88(4):620-5. PubMed ID: 11058880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genes.
    Wada T; Berggren P; Steineck G; Adolfsson J; Wijkström H; Norming U; Hansson J; Hemminki K; Larsson P
    Scand J Urol Nephrol; 2003; 37(2):106-11. PubMed ID: 12745717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular alterations of E-cadherin gene: possible role in human bladder carcinogenesis.
    Taddei I; Piazzini M; Bartoletti R; Dal Canto M; Sardi I
    Int J Mol Med; 2000 Aug; 6(2):201-8. PubMed ID: 10891567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.